{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:17:06Z","timestamp":1759011426196,"version":"3.37.3"},"reference-count":67,"publisher":"Georg Thieme Verlag KG","issue":"03","funder":[{"name":"National Center for Advancing Translational Sciences of the National Institutes of Health","award":["TL1TR002344"],"award-info":[{"award-number":["TL1TR002344"]}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"crossref","award":["UH3-HL138325"],"award-info":[{"award-number":["UH3-HL138325"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive Disease Interventions"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gastrointestinal malignancy encompasses a wide range of disease processes. Its incidence and mortality rate rank among the highest of all cancers. Venous thromboembolic disease is a common complication of gastrointestinal malignancy. Anticoagulation remains the first-line therapy. However, for patients who cannot tolerate or have failed anticoagulation, inferior vena cava (IVC) filter placement may be an option. Furthermore, to improve symptom resolution and reduce the severity of postthrombotic syndrome, catheter-directed thrombolysis (CDT) may be an option. Recent randomized trials including the ATTRACT (Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis) trial have shed new light on the efficacy and safety of CDT and related methods. Overall, the decision to proceed with IVC filter placement or CDT must be individualized.<\/jats:p>","DOI":"10.1055\/s-0040-1716739","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T23:12:34Z","timestamp":1600816354000},"page":"260-266","source":"Crossref","is-referenced-by-count":3,"title":["Gastrointestinal Malignancies and Venous Thromboembolic Disease: Clinical Significance and Endovascular Interventions"],"prefix":"10.1055","volume":"04","author":[{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Section of Interventional Radiology, Imaging Institute, Cleveland Clinic Main Campus, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasan","family":"Partovi","sequence":"additional","affiliation":[{"name":"Section of Interventional Radiology, Imaging Institute, Cleveland Clinic Main Campus, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Gadani","sequence":"additional","affiliation":[{"name":"Section of Interventional Radiology, Imaging Institute, Cleveland Clinic Main Campus, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Charles","family":"Martin","sequence":"additional","affiliation":[{"name":"Section of Interventional Radiology, Imaging Institute, Cleveland Clinic Main Campus, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avi","family":"Beck","sequence":"additional","affiliation":[{"name":"Section of Interventional Radiology, Imaging Institute, Cleveland Clinic Main Campus, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Vedantham","sequence":"additional","affiliation":[{"name":"Section of Interventional Radiology, Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"R L Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1603923","article-title":"Hepatocellular carcinoma: current practice and new frontiers","author":"R Gaba","year":"2017","journal-title":"Dig Dis Interv"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0037-1599255","article-title":"Imaging of cholangiocarcinoma","volume":"1","author":"R S Arellano","year":"2017","journal-title":"Dig Dis Interv"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1692483","article-title":"Ablation techniques in liver and pancreatic cancers","author":"G Mauri","year":"2019","journal-title":"Dig Dis Interv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1688724","article-title":"Thermal ablations for colorectal liver metastases","author":"N Gennaro","year":"2019","journal-title":"Dig Dis Interv"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1645853","article-title":"Stenting for advanced esophageal carcinoma","author":"K Kim","year":"2018","journal-title":"Dig Dis Interv"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1639335","article-title":"Minimally invasive interventional management of gastric outlet obstructions","author":"W Z Zhou","year":"2018","journal-title":"Dig Dis Interv"},{"issue":"08","key":"ref8","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/j.1538-7836.2010.03929.x","article-title":"High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients","volume":"8","author":"R Singh","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","article-title":"Incidence of venous thromboembolism in patients with cancer - a cohort study using linked United Kingdom databases","volume":"49","author":"A J Walker","year":"2013","journal-title":"Eur J Cancer"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","article-title":"Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study","volume":"4","author":"J W Blom","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1148\/radiol.2017151978","article-title":"Stratification, imaging, and management of acute massive and submassive pulmonary embolism","volume":"284","author":"A K Sista","year":"2017","journal-title":"Radiology"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0049-3848(03)00347-5","article-title":"Epidemiology and management of venous thromboembolism in patients with cancer","volume":"110","author":"A YY Lee","year":"2003","journal-title":"Thromb Res"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"P Prandoni","year":"2002","journal-title":"Blood"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12885-020-06930-1","article-title":"Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study","volume":"20","author":"J Howlett","year":"2020","journal-title":"BMC Cancer"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"A A Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.thromres.2009.12.023","article-title":"Venous thromboembolism and prognosis in cancer","volume":"125","author":"A A Khorana","year":"2010","journal-title":"Thromb Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.thromres.2017.07.026","article-title":"Epidemiology of the post-thrombotic syndrome","volume":"164","author":"J P Galanaud","year":"2018","journal-title":"Thromb Res"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archinte.164.1.17","article-title":"Relationship between deep venous thrombosis and the postthrombotic syndrome","volume":"164","author":"S R Kahn","year":"2004","journal-title":"Arch Intern Med"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11936-012-0224-3","article-title":"The post-thrombotic syndrome: a 2012 therapeutic update","volume":"15","author":"J P Galanaud","year":"2013","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jvs.2010.08.050","article-title":"An update on etiology, prevention, and therapy of postthrombotic syndrome","volume":"53","author":"P K Henke","year":"2011","journal-title":"J Vasc Surg"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archinte.162.10.1144","article-title":"Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis","volume":"162","author":"S R Kahn","year":"2002","journal-title":"Arch Intern Med"},{"issue":"06","key":"ref22","first-page":"894","article-title":"Tissue factor expression and metastatic potential of colorectal cancer","volume":"80","author":"C Shigemori","year":"1998","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1158\/1078-0432.CCR-06-2351","article-title":"Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer","volume":"13","author":"A A Khorana","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"05","key":"ref24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000226049","article-title":"Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy","volume":"42","author":"J TW Licciardello","year":"1985","journal-title":"Oncology"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0741-5214(99)70248-X","article-title":"The postthrombotic syndrome in relation to venous hemodynamics, as measured by means of duplex scanning and strain-gauge plethysmography","volume":"29","author":"J H Haenen","year":"1999","journal-title":"J Vasc Surg"},{"issue":"04","key":"ref26","first-page":"825","article-title":"The post-thrombotic syndrome: incidence and prognostic value of non-invasive venous examinations in a six-year follow-up study","volume":"94","author":"E M Roumen-Klappe","year":"2005","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.amjms.2018.03.004","article-title":"Postthrombotic syndrome: long-term sequela of deep venous thrombosis","volume":"356","author":"A Moustafa","year":"2018","journal-title":"Am J Med Sci"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"A YY Lee","year":"2003","journal-title":"N Engl J Med"},{"issue":"07","key":"ref29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.9243","article-title":"Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: A randomized clinical trial","volume":"314","author":"A YY Lee","year":"2015","journal-title":"JAMA"},{"issue":"06","key":"ref30","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/jth.12923","article-title":"Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study","volume":"13","author":"C W Francis","year":"2015","journal-title":"J Thromb Haemost"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.thromres.2017.07.004","article-title":"Tinzaparin in cancer associated thrombosis beyond 6months: TiCAT study","volume":"157","author":"L Jara-Palomares","year":"2017","journal-title":"Thromb Res"},{"issue":"07","key":"ref32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"G E Raskob","year":"2018","journal-title":"N Engl J Med"},{"issue":"20","key":"ref33","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: Results of a randomized trial (SELECT-D)","volume":"36","author":"A M Young","year":"2018","journal-title":"J Clin Oncol"},{"issue":"06","key":"ref34","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/jth.14007","article-title":"Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study","volume":"16","author":"P W Kamphuisen","year":"2018","journal-title":"J Thromb Haemost"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.thromres.2016.12.016","article-title":"Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis","volume":"150","author":"J A Ross","year":"2017","journal-title":"Thromb Res"},{"issue":"02","key":"ref36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11912-019-0767-5","article-title":"Anticoagulation in cancer patients: a summary of pitfalls to avoid","volume":"21","author":"H K Patel","year":"2019","journal-title":"Curr Oncol Rep"},{"issue":"06","key":"ref37","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/jth.14015","article-title":"Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH","volume":"16","author":"B T Samuelson Bannow","year":"2018","journal-title":"J Thromb Haemost"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.thromres.2016.07.013","article-title":"Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?","volume":"145","author":"A A Khorana","year":"2016","journal-title":"Thromb Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a000887","article-title":"Inferior vena cava filter \u2013 comprehensive overview of current indications, techniques, complications and retrieval rates","author":"X Li","year":"2020","journal-title":"J Vasc Med"},{"issue":"05","key":"ref40","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"N S Key","year":"2020","journal-title":"J Clin Oncol"},{"issue":"05","key":"ref41","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.thromres.2015.02.002","article-title":"Vena cava filter use in cancer patients with acute venous thromboembolism in California","volume":"135","author":"G Ho","year":"2015","journal-title":"Thromb Res"},{"issue":"05","key":"ref42","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jvsv.2017.05.017","article-title":"Impact of an inferior vena cava filter retrieval algorithm on filter retrieval rates in a cancer population","volume":"5","author":"R J Litwin","year":"2017","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"06","key":"ref43","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s12032-015-0622-y","article-title":"Retrievable inferior vena cava filters in patients with cancer are safe but are they beneficial?","volume":"32","author":"S Mikhail","year":"2015","journal-title":"Med Oncol"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.amjmed.2014.06.025","article-title":"Inferior vena cava filter usage, complications, and retrieval rate in cancer patients","volume":"127","author":"F Abtahian","year":"2014","journal-title":"Am J Med"},{"issue":"07","key":"ref45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199802123380701","article-title":"A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Pr\u00e9vention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group","volume":"338","author":"H Decousus","year":"1998","journal-title":"N Engl J Med"},{"issue":"03","key":"ref46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.104.512834","article-title":"Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study","volume":"112","author":"H Decousus","year":"2005","journal-title":"Circulation"},{"issue":"16","key":"ref47","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.2015.3780","article-title":"Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial","volume":"313","author":"P Mismetti","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s00520-012-1413-z","article-title":"Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial","volume":"20","author":"M F Barginear","year":"2012","journal-title":"Support Care Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.thromres.2017.03.012","article-title":"Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE) does not improve clinical outcomes: a population-based study","volume":"153","author":"A Brunson","year":"2017","journal-title":"Thromb Res"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"442.e9","DOI":"10.1016\/j.amjmed.2017.10.039","article-title":"Inferior vena cava filters in patients with acute pulmonary embolism and cancer","volume":"131","author":"P D Stein","year":"2018","journal-title":"Am J Med"},{"issue":"06","key":"ref51","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1212\/WNL.43.6.1111","article-title":"Complications of therapy for venous thromboembolic disease in patients with brain tumors","volume":"43","author":"J M Levin","year":"1993","journal-title":"Neurology"},{"issue":"04","key":"ref52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.hemonc.2014.09.005","article-title":"Inferior vena cava filters in patients with advanced-stage cancer","volume":"7","author":"A Mansour","year":"2014","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)61753-4","article-title":"Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial","volume":"379","author":"T Enden","year":"2012","journal-title":"Lancet"},{"issue":"02","key":"ref54","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S2352-3026(15)00248-3","article-title":"Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial","volume":"3","author":"Y Haig","year":"2016","journal-title":"Lancet Haematol"},{"issue":"S 03","key":"ref55","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.21037\/cdt.2017.09.15","article-title":"Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations","volume":"7","author":"D Fleck","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"issue":"23","key":"ref56","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa1615066","article-title":"Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis","volume":"377","author":"S Vedantham","year":"2017","journal-title":"N Engl J Med"},{"issue":"04","key":"ref57","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-0039-1677795","article-title":"Pharmacomechanical catheter-directed thrombolysis in acute femoral-popliteal deep vein thrombosis: analysis from a stratified randomized trial","volume":"119","author":"C Kearon","year":"2019","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref58","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/CIRCULATIONAHA.118.037425","article-title":"Endovascular thrombus removal for acute iliofemoral deep vein thrombosis","volume":"139","author":"A J Comerota","year":"2019","journal-title":"Circulation"},{"issue":"01","key":"ref59","first-page":"8-23.e18","article-title":"Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis","volume":"8","author":"S R Kahn","year":"2020","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"10","key":"ref60","doi-asserted-by":"crossref","first-page":"e005659","DOI":"10.1161\/CIRCOUTCOMES.119.005659","article-title":"Cost-effectiveness of pharmacomechanical catheter-directed thrombolysis versus standard anticoagulation in patients with proximal deep vein thrombosis: Results from the ATTRACT trial","volume":"12","author":"E A Magnuson","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"01","key":"ref61","doi-asserted-by":"crossref","first-page":"e002027","DOI":"10.1161\/CIRCINTERVENTIONS.114.002027","article-title":"Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis","volume":"8","author":"R P Engelberger","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"issue":"01","key":"ref62","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/S2352-3026(19)30209-1","article-title":"Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial","volume":"7","author":"P Notten","year":"2020","journal-title":"Lancet Haematol"},{"issue":"03","key":"ref63","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1051-0443(97)70581-5","article-title":"Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy","volume":"8","author":"H Bjarnason","year":"1997","journal-title":"J Vasc Interv Radiol"},{"key":"ref64","first-page":"CD002783","article-title":"Thrombolysis for acute deep vein thrombosis","volume":"11","author":"L Watson","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"09","key":"ref65","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jvir.2014.04.019","article-title":"Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal","volume":"25","author":"S Vedantham","year":"2014","journal-title":"J Vasc Interv Radiol"},{"issue":"02","key":"ref66","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jvs.2007.10.033","article-title":"Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients","volume":"47","author":"H S Kim","year":"2008","journal-title":"J Vasc Surg"},{"issue":"04","key":"ref67","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jvsv.2019.10.014","article-title":"In-hospital outcomes of catheter-directed thrombolysis versus anticoagulation in cancer patients with proximal deep venous thrombosis","volume":"8","author":"Y Brailovsky","year":"2020","journal-title":"J Vasc Surg Venous Lymphat Disord"}],"container-title":["Digestive Disease Interventions"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0040-1716739.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T23:43:56Z","timestamp":1603755836000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0040-1716739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":67,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2020,10,26]]},"published-print":{"date-parts":[[2020,9]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0040-1716739","relation":{},"ISSN":["2472-8721","2472-873X"],"issn-type":[{"type":"print","value":"2472-8721"},{"type":"electronic","value":"2472-873X"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}